Please use this identifier to cite or link to this item:
https://doi.org/10.1371/journal.pone.0192717
DC Field | Value | |
---|---|---|
dc.title | Doxycycline inhibits experimental cerebral malaria by reducing inflammatory immune reactions and tissue-degrading mediators | |
dc.contributor.author | Schmidt K.E. | |
dc.contributor.author | Kuepper J.M. | |
dc.contributor.author | Schumak B. | |
dc.contributor.author | Alferink J. | |
dc.contributor.author | Hofmann A. | |
dc.contributor.author | Howland S.W. | |
dc.contributor.author | Rénia L. | |
dc.contributor.author | Limmer A. | |
dc.contributor.author | Specht S. | |
dc.contributor.author | Hoerauf A. | |
dc.date.accessioned | 2020-03-27T01:05:28Z | |
dc.date.available | 2020-03-27T01:05:28Z | |
dc.date.issued | 2018 | |
dc.identifier.citation | Schmidt K.E., Kuepper J.M., Schumak B., Alferink J., Hofmann A., Howland S.W., Rénia L., Limmer A., Specht S., Hoerauf A. (2018). Doxycycline inhibits experimental cerebral malaria by reducing inflammatory immune reactions and tissue-degrading mediators. PLoS ONE 13 (2) : e0192717. ScholarBank@NUS Repository. https://doi.org/10.1371/journal.pone.0192717 | |
dc.identifier.issn | 19326203 | |
dc.identifier.uri | https://scholarbank.nus.edu.sg/handle/10635/165969 | |
dc.description.abstract | Malaria ranks among the most important infectious diseases worldwide and affects mostly people living in tropical countries. Mechanisms involved in disease progression are still not fully understood and specific treatments that might interfere with cerebral malaria (CM) are limited. Here we show that administration of doxycycline (DOX) prevented experimental CM (ECM) in Plasmodium berghei ANKA (PbA)-infected C57BL/6 wildtype (WT) mice in an IL-10-independent manner. DOX-treated mice showed an intact blood-brain barrier (BBB) and attenuated brain inflammation. Importantly, if WT mice were infected with a 20-fold increased parasite load, they could be still protected from ECM if they received DOX from day 4–6 post infection, despite similar parasitemia compared to control-infected mice that did not receive DOX and developed ECM. Infiltration of T cells and cytotoxic responses were reduced in brains of DOX-treated mice. Analysis of brain tissue by RNA-array revealed reduced expression of chemokines and tumour necrosis factor (TNF) in brains of DOX-treated mice. Furthermore, DOX-administration resulted in brains of the mice in reduced expression of matrix metalloproteinase 2 (MMP2) and granzyme B, which are both factors associated with ECM pathology. Systemic interferon gamma production was reduced and activated peripheral T cells accumulated in the spleen in DOX-treated mice. Our results suggest that DOX targeted inflammatory processes in the central nervous system (CNS) and prevented ECM by impaired brain access of effector T cells in addition to its anti-parasitic effect, thereby expanding the understanding of molecular events that underlie DOX-mediated therapeutic interventions. © 2018 Schmidt et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. | |
dc.publisher | Public Library of Science | |
dc.source | Unpaywall 20200320 | |
dc.subject | chemokine | |
dc.subject | doxycycline | |
dc.subject | gamma interferon | |
dc.subject | gelatinase A | |
dc.subject | granzyme B | |
dc.subject | interleukin 10 | |
dc.subject | tumor necrosis factor | |
dc.subject | antimalarial agent | |
dc.subject | autacoid | |
dc.subject | chemokine | |
dc.subject | doxycycline | |
dc.subject | gelatinase A | |
dc.subject | gelatinase B | |
dc.subject | IL10 protein, mouse | |
dc.subject | interleukin 10 | |
dc.subject | Mmp2 protein, mouse | |
dc.subject | Mmp9 protein, mouse | |
dc.subject | animal cell | |
dc.subject | animal experiment | |
dc.subject | animal model | |
dc.subject | animal tissue | |
dc.subject | Article | |
dc.subject | blood brain barrier | |
dc.subject | CD8+ T lymphocyte | |
dc.subject | cell isolation | |
dc.subject | cerebral malaria | |
dc.subject | controlled study | |
dc.subject | cytotoxicity | |
dc.subject | disease course | |
dc.subject | encephalitis | |
dc.subject | enzyme linked immunosorbent assay | |
dc.subject | female | |
dc.subject | immunity | |
dc.subject | in vivo study | |
dc.subject | lymphocytic infiltration | |
dc.subject | mouse | |
dc.subject | nonhuman | |
dc.subject | parasite load | |
dc.subject | parasitemia | |
dc.subject | pathology | |
dc.subject | Plasmodium berghei | |
dc.subject | protein expression | |
dc.subject | real time polymerase chain reaction | |
dc.subject | RNA isolation | |
dc.subject | spleen cell | |
dc.subject | T lymphocyte | |
dc.subject | tissue degeneration | |
dc.subject | zymography | |
dc.subject | animal | |
dc.subject | C57BL mouse | |
dc.subject | cerebral malaria | |
dc.subject | disease model | |
dc.subject | drug effects | |
dc.subject | immunology | |
dc.subject | inflammation | |
dc.subject | lymphocyte activation | |
dc.subject | metabolism | |
dc.subject | parasitemia | |
dc.subject | parasitology | |
dc.subject | pathogenicity | |
dc.subject | spleen | |
dc.subject | T lymphocyte subpopulation | |
dc.subject | Animals | |
dc.subject | Antimalarials | |
dc.subject | Blood-Brain Barrier | |
dc.subject | Chemokines | |
dc.subject | Disease Models, Animal | |
dc.subject | Doxycycline | |
dc.subject | Female | |
dc.subject | Inflammation | |
dc.subject | Inflammation Mediators | |
dc.subject | Interleukin-10 | |
dc.subject | Lymphocyte Activation | |
dc.subject | Malaria, Cerebral | |
dc.subject | Matrix Metalloproteinase 2 | |
dc.subject | Matrix Metalloproteinase 9 | |
dc.subject | Mice | |
dc.subject | Mice, Inbred C57BL | |
dc.subject | Parasitemia | |
dc.subject | Plasmodium berghei | |
dc.subject | Spleen | |
dc.subject | T-Lymphocyte Subsets | |
dc.type | Article | |
dc.contributor.department | MICROBIOLOGY AND IMMUNOLOGY | |
dc.description.doi | 10.1371/journal.pone.0192717 | |
dc.description.sourcetitle | PLoS ONE | |
dc.description.volume | 13 | |
dc.description.issue | 2 | |
dc.description.page | e0192717 | |
Appears in Collections: | Staff Publications Elements |
Show simple item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_1371_journal_pone_0192717.pdf | 2.81 MB | Adobe PDF | OPEN | None | View/Download |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.